<DOC>
	<DOC>NCT00450437</DOC>
	<brief_summary>This study will evaluate the lot to lot consistency, safety and immune response of the Novartis Meningococcal ACWY conjugate vaccine in healthy US adolescents and adults.</brief_summary>
	<brief_title>A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis, Meningococcal</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Lactitol</mesh_term>
	<criteria>Healthy subjects who are 1155 years of age inclusive and who have given appropriate written assent and/or consent Subjects with a previous or suspected disease caused by N. meningitidis previous immunization with a meningococcal vaccine or vaccine containing meningococcal antigen(s) previous or suspected disease caused by N. meningitidis Any serious acute, chronic or progressive disease Pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Meningococcal</keyword>
	<keyword>meningitis</keyword>
	<keyword>vaccine</keyword>
	<keyword>adolescents</keyword>
	<keyword>adults</keyword>
</DOC>